Disease areas
Cardiology
Mapping prevention, diagnostics and access pathways for cardiovascular care.
Cardiometabolic
Tracking risk, prevention and access in metabolic and vascular health.
Eye Disease
Following diagnostics, treatment access and equity in vision care.
Infectious disease
Tracking diagnostics, resistance, prevention and access across infection pathways.
Neurology
Mapping early diagnosis, biomarkers and access in brain health.
Oncology
Following testing, treatment access and equity across cancer pathways.
Cardiology
See all →
Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
Ultra-processed food may leave a metabolic fingerprint in the blood.
New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Moldova Is Taking Vaccines To Roma Communities. Respect Is Part Of Delivery.
Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems
Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy
Indigenous cardiovascular inequity is not a data gap. It is a policy failure
Cardiology has too many dashboards. The danger is forgetting the patient
GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up
Pregnancy complications demand long-term cardiovascular care
Cardiometabolic
See all →Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
Ultra-processed food may leave a metabolic fingerprint in the blood.
Sugar substitutes were sold as metabolic shortcuts. The evidence is getting harder to ignore
Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy
Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate
GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up
MENA’s cardiometabolic crisis is a stability issue
Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach
Half of CKM patients go untreated and most fail control
Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice
Eye Disease
See all →
The Most Preventable Cause of Vision Loss May Still Be Smoking
Cellular Reprogramming Enters Neuro-Ophthalmology
Not All Eye Infections Are Equal: New Evidence Points to a Precision Medicine Approach
The Air We Breathe May Be Shaping the Future Burden of Blindness
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Diabetic Eye Screening Is Becoming Risk-Based
Abu Dhabi Puts Rare Eye Gene Therapy on the Regional Map
AI Eye Screening Has an Image Quality Problem
AI Retinal Screening Moves Into the Diabetes Clinic
Geographic Atrophy Forces Europe to Define Meaningful Vision Benefit
Infectious disease
See all →
Europe Built Seasonal COVID Campaigns. Most Older Adults Were Not Reached.
Ebola Has Passed 2,000 Cases. The Response Is Still Chasing It.
Ebola May Be Reaching Kisangani. Containment Cannot Stay Provincial.
Disaster Shelters Save Lives. Infection Control Cannot Be Improvised.
Cyclospora Is Spreading. The Food Chain Still Has No Answer.
NTDs Are Now A Human-Rights Issue. Budgets Must Follow.
Europe Can Forecast Vibrio Risk. It Still Has To Act.
Mpox Reached Guinea-Bissau. Stigma Must Not Win.
West Nile Is Back. Blood Safety Cannot Lag.
Bird Flu Reached NSW. Biosecurity Is On Trial.
Neurology
See all →
When Dementia Takes Speech, Trials Must Catch Up
Child Mental Health Access Still Depends on the Facility
Huntington’s Gets Another Chance at Proof
Duchenne Evidence Moves Into the Muscle
Migraine Prevention Gets a Wider Door
Stroke Rehab Cannot Stop at Survival
Alzheimer’s Trials Are Finally Blood-Gated
MS Regulators Are No Longer Reading the Same Risk
Europe Opens the SMA Gene-Therapy Door Wider
ALS Needs Proof, Not Just Another Biomarker
Oncology
See all →
Desmoid Tumours Are Not Benign to the People Living With Them
Pancreatic Cancer Is Forcing Regulators to Move Faster
Ultra-processed food may leave a metabolic fingerprint in the blood.
Medicare Is Coming for the Oncology Margin
Early Lung Cancer Just Became a Biomarker Test of the System
Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker
KRAS Has a New Contender. It Still Has to Earn Its Place.
China’s Biliary-Cancer Bet Has a Global Access Problem
A CE Mark Is Not Access